Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Invivyd Inc., 3 years.
Invivyd Inc.
Director
X4 Pharmaceuticals Inc.
Director
Mereo BioPharma Group plc
Director
Tvardi Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2025 | X4 Pharmaceuticals Inc. | Grant or award | +1,500 | — | — |
| Jun 17, 2024 | Mereo BioPharma Group plc | Grant or award | +25,050 | $3.99 | $99,950 |
| Jun 10, 2024 | X4 Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
| Aug 18, 2023 | X4 Pharmaceuticals Inc. | Open-market purchase | +25,000 | $1.20 | $30,000 |
| Jun 13, 2023 | X4 Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
Questions about Michael S. Wyzga
What boards is Michael S. Wyzga on?
Michael S. Wyzga sits on the boards of Invivyd Inc., Mereo BioPharma Group plc, Tvardi Therapeutics Inc. and X4 Pharmaceuticals Inc.
How long has Michael S. Wyzga served on boards?
Our records show at least 11 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.